-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down to $1.86
Bionano Genomics (NASDAQ:BNGO) Shares Gap Down to $1.86
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) shares gapped down prior to trading on Monday . The stock had previously closed at $1.86, but opened at $1.77. Bionano Genomics shares last traded at $1.88, with a volume of 41,758 shares traded.
Analyst Upgrades and Downgrades
Separately, Oppenheimer reaffirmed an "outperform" rating and set a $12.00 target price on shares of Bionano Genomics in a research note on Monday, July 18th.
Get Bionano Genomics alerts:Bionano Genomics Price Performance
The business's 50 day simple moving average is $2.37 and its 200-day simple moving average is $1.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.75.
Bionano Genomics (NASDAQ:BNGO – Get Rating) last released its quarterly earnings data on Thursday, August 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). Bionano Genomics had a negative net margin of 453.68% and a negative return on equity of 33.21%. The firm had revenue of $6.67 million for the quarter, compared to analyst estimates of $6.20 million. Equities analysts forecast that Bionano Genomics, Inc. will post -0.44 EPS for the current fiscal year.Insider Activity at Bionano Genomics
In related news, Director Yvonne Linney sold 20,000 shares of Bionano Genomics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $3.62, for a total value of $72,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Blackston Financial Advisory Group LLC bought a new stake in Bionano Genomics in the 4th quarter valued at $30,000. Merit Financial Group LLC bought a new position in Bionano Genomics during the first quarter worth about $28,000. Freestone Capital Holdings LLC acquired a new stake in Bionano Genomics during the first quarter valued at approximately $29,000. Magnus Financial Group LLC bought a new stake in shares of Bionano Genomics in the 1st quarter valued at approximately $33,000. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Bionano Genomics in the 1st quarter worth approximately $33,000. 28.44% of the stock is owned by institutional investors.
Bionano Genomics Company Profile
(Get Rating)
Bionano Genomics, Inc provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
Further Reading
- Get a free copy of the StockNews.com research report on Bionano Genomics (BNGO)
- Three Consumer Stocks That Could Outperform In Q4
- Comcast is an Asset Bonanza Priced Cheap
- Will Synthetic Biology Firm Amyris Post Net Income In 2024?
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) shares gapped down prior to trading on Monday . The stock had previously closed at $1.86, but opened at $1.77. Bionano Genomics shares last traded at $1.88, with a volume of 41,758 shares traded.
生物纳米基因组公司(纳斯达克代码：BNGO-GET Rating)的股价周一开盘前大幅下跌。该股此前收盘报1.86美元，开盘报1.77美元。生物纳米基因组公司的股票最新报1.88美元，总成交量为41,758股。
Analyst Upgrades and Downgrades
分析师升级和下调评级
Separately, Oppenheimer reaffirmed an "outperform" rating and set a $12.00 target price on shares of Bionano Genomics in a research note on Monday, July 18th.
另外，奥本海默在7月18日(星期一)的一份研究报告中重申了对Bionano Genonics的评级，并为其股票设定了12.00美元的目标价。
Bionano Genomics Price Performance
生物纳米基因组学性价比
The business's 50 day simple moving average is $2.37 and its 200-day simple moving average is $1.99. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.01 and a current ratio of 7.75.
该业务的50日简单移动均线切入位在2.37美元，200日简单移动均线切入位在1.99美元。该公司的负债权益比率为0.01，速动比率为7.01，流动比率为7.75。
Insider Activity at Bionano Genomics
Bionano基因组公司的内部活动
In related news, Director Yvonne Linney sold 20,000 shares of Bionano Genomics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $3.62, for a total value of $72,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.20% of the stock is currently owned by company insiders.
在相关新闻中，董事伊冯·林尼在8月15日(星期一)的一笔交易中出售了20,000股Bionano基因公司的股票。这些股票的平均价格为3.62美元，总价值为72,400.00美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。1.20%的股份目前由公司内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
Institutional investors have recently made changes to their positions in the stock. Blackston Financial Advisory Group LLC bought a new stake in Bionano Genomics in the 4th quarter valued at $30,000. Merit Financial Group LLC bought a new position in Bionano Genomics during the first quarter worth about $28,000. Freestone Capital Holdings LLC acquired a new stake in Bionano Genomics during the first quarter valued at approximately $29,000. Magnus Financial Group LLC bought a new stake in shares of Bionano Genomics in the 1st quarter valued at approximately $33,000. Finally, Resources Investment Advisors LLC. acquired a new position in shares of Bionano Genomics in the 1st quarter worth approximately $33,000. 28.44% of the stock is owned by institutional investors.
机构投资者最近改变了他们在该股的头寸。Blackston Financial Consulting Group LLC在第四季度以3万美元的价格购买了Bionano基因组公司的新股份。优点金融集团有限责任公司在第一季度购买了Bionano基因组公司的一个新头寸，价值约28,000美元。Frestone Capital Holdings LLC在第一季度收购了Bionano基因组公司的新股份，价值约2.9万美元。Magnus Financial Group LLC在第一季度购买了Bionano Genology的新股份，价值约33,000美元。最后，资源投资顾问有限责任公司。在第一季度收购了Bionano基因组公司的新股票，价值约33,000美元。28.44%的股份由机构投资者持有。
Bionano Genomics Company Profile
生物纳米基因组公司简介
(Get Rating)
(获取评级)
Bionano Genomics, Inc provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
生物纳米基因组公司提供基因组分析软件解决方案。它提供了用于通过光学基因组图谱进行结构变异分析的样本到结果的解决方案，用于基因组分析和了解遗传变异和功能；SAHERR仪器，一个单分子成像仪；SETRUR芯片，一个包装用于DNA线性化的纳米通道阵列的消耗品；以及Bionano制备试剂盒和DNA标记试剂盒，它提供了提取和标记超高分子量的试剂和协议。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Bionano Genomics (BNGO)
- Three Consumer Stocks That Could Outperform In Q4
- Comcast is an Asset Bonanza Priced Cheap
- Will Synthetic Biology Firm Amyris Post Net Income In 2024?
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- 免费获取StockNews.com关于Bionano基因组学的研究报告(BNGO)
- 三只可能在第四季度表现优异的消费类股
- 康卡斯特是廉价的资产财源
- 合成生物学公司Amyris将在2024年实现净收益吗？
- 卡特彼勒能否在下跌的市场中走得更高？
- Dave&Buster‘s能免受高通胀和低支出的影响吗？
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.
获得Bionano基因组学日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Bionano Genonics和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧